After release to the extracellular space, HMGB1 acts as a damage-associated molecular pattern molecule (DAMP) that critically mediates inflammation and immune responses in various conditions, including sepsis, atherosclerosis, arthritis, neurodegeneration, meningitis, and cancer. Here, HMGB1 is linked to cancer.